Chip has served as a member of Celcuity’s board of directors since February 2026. Mr. Romp has over 25 years of experience building the pharmaceutical commercialization process from development stage to successful global product. Mr. Romp is currently Chief Executive Officer at Secura Bio. Previously, he was Executive Vice President, US Commercial for Seagen, Inc., prior to the company’s acquisition by Pfizer, where he oversaw the entire Seagen Commercial organization in addition to broader roles in corporate communications, investor relations, and business development as a member of the executive committee. Prior to Seagen, Mr. Romp spent 12 years at Genentech in a wide range of sales, marketing, and development roles spanning their entire oncology and immunology product portfolio. Mr. Romp received a Bachelor of Arts from the University of Florida and an MBA from Saint Leo University in Florida.
